Alcon expands leadership position in treating glaucoma through acquisition of Transcend Medical, Inc
Alcon, the global leader in eye care and a division of Novartis, announced today that it has entered into an agreement to acquire Transcend Medical, Inc., a privately-held, US-based company focused on developing minimally-invasive surgical devices to treat glaucoma.
Click on this link for more information.
